[Plasma thyroglobulin in treated hypothyroidism in children].

Area of Science:

• Pediatric Endocrinology
• Thyroidology
• Clinical Chemistry

Context:

• Hypothyroidism management requires careful monitoring, especially in children receiving L-thyroxine (LT) substitution therapy.
• Re-evaluating treatment effectiveness and classification necessitates reliable biomarkers.
• Thyroglobulin (Tg) and free thyroxine (FT4) are key hormones in thyroid function assessment.

Purpose:

• To investigate the utility of plasma thyroglobulin (Tg) levels in assessing L-thyroxine (LT) treatment and classifying hypothyroidism in children.
• To compare Tg levels in children with normal thyroid glands versus those with ectopic or hypoplastic thyroid glands.
• To explore the correlation between Tg levels and potential L-thyroxine excess.

Summary:

• Plasma Tg and FT4 levels were analyzed in 42 samples from 21 hypothyroid children (18 months-16 years) on LT treatment, divided into groups with normal thyroids (n=8) and ectopic/hypoplastic glands (n=13).
• Tg was undetectable in some, but measurable in others. In children with ectopic/hypoplastic glands, Tg levels were comparable to controls, but lower in cases of suspected LT excess.
• These findings suggest Tg levels may aid in monitoring LT therapy and identifying over-treatment in pediatric hypothyroidism.

Impact:

• Provides insights into using thyroglobulin as a biomarker for optimizing L-thyroxine dosage in pediatric hypothyroidism.
• Highlights the potential for Tg measurement to identify L-thyroxine excess, preventing overtreatment and associated complications.
• Contributes to improved diagnostic and therapeutic strategies for congenital and acquired hypothyroidism in children.